Basiliximab induction versus no induction in adult heart transplantation.

Katelyn N RudzikRyan M RivosecchiBrittany A PalmerGavin W HickeyJessica H HustonMary E KeeblerDavid J KaczorowskiEdward T Horn

Published in: Clinical transplantation (2023)

BAS appears to be associated with greater freedom from rejection without an increase in infections. BAS may be a preferred to a no induction strategy in patients undergoing heart transplantation.

Keyphrases

patients undergoing
young adults